At the recent Innovation Day seminar hosted by Complementary Medicines Australia (CMA), Gnosis by Lesaffre, led by Jose Pinedo Rivera, Product Manager, had the opportunity to present MyCondro™ to an engaged audience of over 250 industry professionals. The session, “Keeping Pace with a Changing World: MyCondro™ Disrupts the Chondroitin Sulfate Market,” was well received, sparking interest and conversations around the future of joint health solutions.
Addressing Industry Challenges With Proven Science
MyCondro™ stood out as a breakthrough solution addressing the limitations of animal-based chondroitin, including supply chain variability, risk of contamination, and ethical concerns. Through the presentation, Gnosis highlighted how this fermentation-derived ingredient delivers 45% higher bioavailability, proven clinical efficacy at a lower dosage, and consistent purity that surpasses regulatory standards. As the world shifts toward cleaner, more responsible nutraceuticals, MyCondro™ emerged as a compelling option for brands looking to innovate and meet consumer expectations.
Engaging One-to-One: Bringing Innovation Closer
In addition to the presentation, The Gnosis booth at the CMA event allowed connection with attendees in more personal, one-to-one discussions. These interactions offered a valuable platform to explain further why MyCondro™ matters—its scientific foundation, production innovation, and potential for expanded applications in areas like metabolic health and inflammation management. Overall, the seminar was a successful moment to communicate not just what Gnosis offers, but why and how the company is leading the transformation of the joint health category.
Furthermore, the structure of MyCondro™ closely resembles human synovial fluid, which may contribute to its efficacy in promoting joint health. Its low molecular weight and homogeneous composition enhance its bioactivity, making it a promising option for individuals seeking to maintain joint function and mobility.
Do you need more information about MyCondro™ or have any outstanding questions? Please do not hesitate to contact us; our expert team will happily answer!
Other Active Ingredients
Quatrefolic®
Active ingredients
Folate: An innovative dietary ingredient designed to act as a nutrient in all areas where folic acid and folate supplementation is recommended and allowed.
Reproduction & Women’s
Wellness & Immune
Mobility & Joint
Fertility
Pregnancy
Menopause
MenaQ7®
- Active ingredients
Vitamin K2: MenaQ7® is the optimal bioavailable 99.8% all-trans vitamin K2 as MK-7, produced in the only European plant manufacturing K2 by natural fermentation under the highest quality standards and sustainability measures.
- Mobility & Joint
- Wellness & Immune
- Reproduction & Women’s
Bone
Cardiovascular- Menopause
MyCondro™
- Active ingredients
Chondroitin sulfate: A fermentation-derived form of chondroitin sulfate, an ingredient linked with superior joint health. Chondroitin sulfate has become widely used as a dietary supplement to help keep joints healthy and treat osteoarthritis.
- Mobility & Joint
Digestion & Gut
Joint
Sports Nutrition
Digestive Comfort
Latest news
- News
- Quatrefolic®
- Wellness & Immune
- Jun 12, 2025
Webinar Rethinking Women’s Health 24 June 2025
Women's health is complex, constantly evolving, and a broader perspective is long overdue, one...
- News
- Quatrefolic®
- Wellness & Immune
- Jun 09, 2025
Gnosis by Lesaffre Highlights Quatrefolic® at New Nutrition Forum in Hangzhou, China
Gnosis by Lesaffre was proud to serve as the Title Sponsor of the New...
- Corporate
- Digestion & Gut
- News
- Jun 06, 2025
Biotic Live: A Successful First Edition Exploring the Power of Probiotic Yeasts
Gnosis by Lesaffre recently hosted the first edition of Biotic Live, a unique event...
